GeneticCounselingMethotrexateBreastTomosynthesisAntiemeticPrecisionMedicinePARPInhibitorsRelapseRADBilateralProphylacticMastectomymTORInhibitorsAdvocacyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltACChemotherapyCheckpointInhibitorKi-67RateEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearCytostaticDefinitiveSurgeryMRIMultimodalityTherapyCachexiaTumorGradeKappaEpsilonHormoneReceptorStatusMegestrolAcetateGeneticPredispositionAlopeciaBI-RADSAbsoluteRiskIn-situCarcinomaEstrogenEstradiolCyclophosphamideCo-survivor5-FluorouracilTyrosine-KinaseInhibitorSelf-examinationPalbociclibAntibodyTherapyAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerAngiogenesisLymphoscintigraphyRaloxifeneDoxorubicinGailModelPathologicResponseOvarianSuppressionBevacizumabGenomicTestingHormoneReplacementTherapyBrachytherapyAyurvedaAromataseInhibitorsER-PalpationFibroadenomaAxillarySamplingBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55CalcificationsPagetDiseaseChemopreventionAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenER+HerceptinEGFRFISHPaclitaxelSERMHER-2LumpectomyGuaranteedRenewableInsuranceLapatinibChemotherapyLCISGermlineMutationDown-StagingIntraductalPapillomaBreastCancerCytotoxicBOCAPhysicalactivity mayreduce therisk of breastcancersPI3KinaseInhibitorsCMFChemotherapyApoptosis1 in 8womenImmunotherapyLymphNodeStatusFlowCytometryAnastrozoleMastectomyOligometastasesCDK4/6InhibitorsDoseDenseTherapyCystLumpFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.ECOGScoreNeoadjuvantTherapyStagingDimplingMultifocalTumorsAdjuvantTherapyWomen ages40+ shouldhave a clinicalbreast examat least yearlyMastodyniaProgestinMorpheaAdenocarcinomaRadiotherapyDocetaxelPhyllodesTumorWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.CapecitabineMetastasisTriple +/-BreastCancerGeneMutationTamoxifenFamilyHistoryBiopsyBRCAGeneCAMGeneticCounselingMethotrexateBreastTomosynthesisAntiemeticPrecisionMedicinePARPInhibitorsRelapseRADBilateralProphylacticMastectomymTORInhibitorsAdvocacyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltACChemotherapyCheckpointInhibitorKi-67RateEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearCytostaticDefinitiveSurgeryMRIMultimodalityTherapyCachexiaTumorGradeKappaEpsilonHormoneReceptorStatusMegestrolAcetateGeneticPredispositionAlopeciaBI-RADSAbsoluteRiskIn-situCarcinomaEstrogenEstradiolCyclophosphamideCo-survivor5-FluorouracilTyrosine-KinaseInhibitorSelf-examinationPalbociclibAntibodyTherapyAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerAngiogenesisLymphoscintigraphyRaloxifeneDoxorubicinGailModelPathologicResponseOvarianSuppressionBevacizumabGenomicTestingHormoneReplacementTherapyBrachytherapyAyurvedaAromataseInhibitorsER-PalpationFibroadenomaAxillarySamplingBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55CalcificationsPagetDiseaseChemopreventionAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenER+HerceptinEGFRFISHPaclitaxelSERMHER-2LumpectomyGuaranteedRenewableInsuranceLapatinibChemotherapyLCISGermlineMutationDown-StagingIntraductalPapillomaBreastCancerCytotoxicBOCAPhysicalactivity mayreduce therisk of breastcancersPI3KinaseInhibitorsCMFChemotherapyApoptosis1 in 8womenImmunotherapyLymphNodeStatusFlowCytometryAnastrozoleMastectomyOligometastasesCDK4/6InhibitorsDoseDenseTherapyCystLumpFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.ECOGScoreNeoadjuvantTherapyStagingDimplingMultifocalTumorsAdjuvantTherapyWomen ages40+ shouldhave a clinicalbreast examat least yearlyMastodyniaProgestinMorpheaAdenocarcinomaRadiotherapyDocetaxelPhyllodesTumorWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.CapecitabineMetastasisTriple +/-BreastCancerGeneMutationTamoxifenFamilyHistoryBiopsyBRCAGeneCAM

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
  1. Genetic Counseling
  2. Methotrexate
  3. Breast Tomosynthesis
  4. Antiemetic
  5. Precision Medicine
  6. PARP Inhibitors
  7. Relapse
  8. RAD
  9. Bilateral Prophylactic Mastectomy
  10. mTOR Inhibitors
  11. Advocacy
  12. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  13. AC Chemotherapy
  14. Checkpoint Inhibitor
  15. Ki-67 Rate
  16. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  17. Cytostatic
  18. Definitive Surgery
  19. MRI
  20. Multimodality Therapy
  21. Cachexia
  22. Tumor Grade
  23. Kappa Epsilon
  24. Hormone Receptor Status
  25. Megestrol Acetate
  26. Genetic Predisposition
  27. Alopecia
  28. BI-RADS
  29. Absolute Risk
  30. In-situ Carcinoma
  31. Estrogen
  32. Estradiol
  33. Cyclophosphamide
  34. Co-survivor
  35. 5-Fluorouracil
  36. Tyrosine-Kinase Inhibitor
  37. Self-examination
  38. Palbociclib
  39. Antibody Therapy
  40. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  41. Angiogenesis
  42. Lymphoscintigraphy
  43. Raloxifene
  44. Doxorubicin
  45. Gail Model
  46. Pathologic Response
  47. Ovarian Suppression
  48. Bevacizumab
  49. Genomic Testing
  50. Hormone Replacement Therapy
  51. Brachytherapy
  52. Ayurveda
  53. Aromatase Inhibitors
  54. ER-
  55. Palpation
  56. Fibroadenoma
  57. Axillary Sampling
  58. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  59. Calcifications
  60. Paget Disease
  61. Chemoprevention
  62. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  63. ER+
  64. Herceptin
  65. EGFR
  66. FISH
  67. Paclitaxel
  68. SERM
  69. HER-2
  70. Lumpectomy
  71. Guaranteed Renewable Insurance
  72. Lapatinib
  73. Chemotherapy
  74. LCIS
  75. Germline Mutation
  76. Down-Staging
  77. Intraductal Papilloma
  78. Breast Cancer
  79. Cytotoxic
  80. BOCA
  81. Physical activity may reduce the risk of breast cancers
  82. PI3 Kinase Inhibitors
  83. CMF Chemotherapy
  84. Apoptosis
  85. 1 in 8 women
  86. Immunotherapy
  87. Lymph Node Status
  88. Flow Cytometry
  89. Anastrozole
  90. Mastectomy
  91. Oligometastases
  92. CDK4/6 Inhibitors
  93. Dose Dense Therapy
  94. Cyst
  95. Lump
  96. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  97. ECOG Score
  98. Neoadjuvant Therapy
  99. Staging
  100. Dimpling
  101. Multifocal Tumors
  102. Adjuvant Therapy
  103. Women ages 40+ should have a clinical breast exam at least yearly
  104. Mastodynia
  105. Progestin
  106. Morphea
  107. Adenocarcinoma
  108. Radiotherapy
  109. Docetaxel
  110. Phyllodes Tumor
  111. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  112. Capecitabine
  113. Metastasis
  114. Triple +/- Breast Cancer
  115. Gene Mutation
  116. Tamoxifen
  117. Family History
  118. Biopsy
  119. BRCA Gene
  120. CAM